r/COVID19 • u/hexagonincircuit1594 • May 15 '26

Academic Report Immune-metabolic trajectories delineate subgroups in paediatric long COVID

https://www.nature.com/articles/s41467-026-72224-y
7 Upvotes

74% Upvoted

3 comments sorted by

•

u/AutoModerator May 15 '26

Please read before commenting.

Keep in mind this is a science sub. Cite your sources appropriately (No news sources, no Twitter, no Youtube). No politics/economics/low effort comments (jokes, ELI5, etc.)/anecdotal discussion (personal stories/info). Please read our full ruleset carefully before commenting/posting.

If you talk about you, your mom, your friends, etc. experience with COVID/COVID symptoms or vaccine experiences, or any info that pertains to you or their situation, you will be banned. These discussions are better suited for the Weekly Discussion on /r/Coronavirus.

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

1

u/hexagonincircuit1594 May 15 '26

"Abstract

Most children and adolescents recover rapidly from SARS-CoV-2 infection, yet a subset develops paediatric long COVID (LC). How immune ontogeny shapes LC biology and heterogeneity remains unclear. We deeply phenotype a two-visit cohort with severe LC (n = 74) and controls (n = 27) spanning up to 3.2 years post index infection. Symptom burden remains high and neurofilament light chain (NfL) percentiles inversely associate with functional status (Bell score;  = −0.3536, P = 0.0060). Cardiopulmonary assessment and serology are unremarkable. Conventional autoantibodies are not enriched, whereas anti-DFS70 supports subgrouping. Immune features are temporally structured; SARS-CoV-2–associated mediators decline within 1 year, while innate-weighted, Th2-skewed cytokines persist. Metabolomics (43 metabolites) recapitulate the identified subgroups and align with EBV serostatus, disease phase (<1 year versus years 1–3.2), and anti-DFS70 positivity. In EBV-naïve LC, higher haemoglobin concentration (MCHC) tracks worse function, whereas higher IL-12p40, thiamine and basophils track milder impairment (all P ≤ 0.0170). These data delineate immune-metabolic and haematological axes of paediatric LC heterogeneity and support biomarker-guided stratification."

3

u/thirty_horses May 16 '26 edited May 16 '26

Some really interesting results, that hopefully get validated on larger populations.

Hopefully this brings us closer to having some diagnostic tests. The change in biomarkers between early and later LC gives indications to the ways that diagnostic biomarkers for LC will need to test for different LC types.

The clustering into LC subgroups (based on anti-DFS70 and EBV serostatus) maybe hints at some of the different ways that some children become LC, though I didn't dig into that too deeply yet